Abx, Steroids, & Antiemetics Flashcards
Risk Factors for SSI
DM Smoking Hypothermia Preoperative shaving Skin antisepsis Antimicrobial prophylaxis Inadequate sterilization of instruments Surgical technique
Redosing Time of Ampicillin and Cefazolin
Depends on the abs half life A: 2 hrs C: 4hrs
Redosing Considerations
Normal renal function: creatine clearance is 100 ml/min
- If < 60 ml/min consider adjusted dosing
Blood loss > 1.5L redone Vance half dose, redone all others full dose
Post-op redose limit to 24 hrs
Clean Wound Organism & Abx & Allergy Abx
staphylococcus aureus & coagulase negative staphylococci
Cefazolin
beta lacatam allergy –> clindamycin or vancomycin
Contaminated Wound Organism, Abx, & Allergy Abx
staphylococcus aureus & streptococci
Cefazolin & metronidazole
beta lactam allergy –> clindamycin
Contaminated Oral Organism, Abx, & Allergy Abx
non-bacteroides fragilis, peptostreptococcus & prevotella
Ampicillin/sulbactam
Beta lactam allergy –> clindamycin
Biliary & GI Wound Organism, Abx, & Allergy Abx
staphylococcus aureus & anaerobic gram – rods
Cefazolin & metronidazole
Beta lactam allergy –> clindamycin + aminoglycoside or fluoroquinolone
Cefazolin
1st gen cephalosporin o MOA: beta lactam antimicrobial. Binds to the PBP (pcn-binding proteins) – inhibition of bacterial cell wall synthesis. Bacteriocidal. Dosing: - 2g for healthy adults - 3g > 120kg - 25 mg/kg < 40 kg - IV push over 3-5 min
Vancomycin
broad spectrum abx
o MOA: Inhibits bacterial cell wall synthesis via inhibition of polymerization of peptidoglycans
- Often for pts with MRSA
Dosing:
- 1g over 1 hr
at least 50% should be infused before procedure
Admin time of Abx
Cephalosporins up to 2 min before incision
Vanco & Flagyl 60 min before
Beta Lactam Abxs & Risks
PCNs, cephalosporins, ampicillin
Risk: Allergic reaction
Aminoglycosides
Gentamycin & Streptomycin
Risk: ototoxicity, nephrotoxicity, skeletal muscle weakness
Tetracyclines
Doxycycline
Risk: Hepatotoxicity, Nephrotoxicity
Fluoroquinolones
Ciprofloxacin, Levofloxacin
Risk: GI intolerance
Macrolides
Erythromycin
Risk: P450 inhibition